431 related articles for article (PubMed ID: 33927720)
1. Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway.
Gui Z; Suo C; Wang Z; Zheng M; Fei S; Chen H; Sun L; Han Z; Tao J; Ju X; Yang H; Gu M; Tan R
Front Immunol; 2021; 12():650424. PubMed ID: 33927720
[TBL] [Abstract][Full Text] [Related]
2. Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only
Gui Z; Suo C; Tao J; Wang Z; Zheng M; Fei S; Chen H; Sun L; Han Z; Ju X; Zhang H; Gu M; Tan R
Front Immunol; 2021; 12():753412. PubMed ID: 35140705
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation.
Zhou J; Yao M; Zhu M; Li M; Ke Q; Wu B; Wang D
Front Immunol; 2021; 12():656242. PubMed ID: 34122411
[TBL] [Abstract][Full Text] [Related]
4. Rictor/mTORC2 signalling contributes to renal vascular endothelial-to-mesenchymal transition and renal allograft interstitial fibrosis by regulating BNIP3-mediated mitophagy.
Feng D; Gui Z; Xu Z; Zhang J; Ni B; Wang Z; Liu J; Fei S; Chen H; Sun L; Gu M; Tan R
Clin Transl Med; 2024 May; 14(5):e1686. PubMed ID: 38769658
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor-β1 Induces Endothelial-to-Mesenchymal Transition via Akt Signaling Pathway in Renal Transplant Recipients with Chronic Allograft Dysfunction.
Wang Z; Han Z; Tao J; Wang J; Liu X; Zhou W; Xu Z; Zhao C; Ju X; Wang Z; Tan R; Gu M
Ann Transplant; 2016 Dec; 21():775-783. PubMed ID: 27994216
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis.
Wang Z; Han Z; Tao J; Wang J; Liu X; Zhou W; Xu Z; Zhao C; Wang Z; Tan R; Gu M
J Cell Mol Med; 2017 Oct; 21(10):2359-2369. PubMed ID: 28374926
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization.
Suo C; Gui Z; Wang Z; Zhou J; Zheng M; Chen H; Fei S; Gu M; Tan R
Clin Sci (Lond); 2021 Jan; 135(1):53-69. PubMed ID: 33289516
[TBL] [Abstract][Full Text] [Related]
8. Role of tumor necrosis factor-α in epithelial-to-mesenchymal transition in transplanted kidney cells in recipients with chronic allograft dysfunction.
Zhao C; Xu Z; Wang Z; Suo C; Tao J; Han Z; Gu M; Tan R
Gene; 2018 Feb; 642():483-490. PubMed ID: 29174387
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
Schauerte C; Hübner A; Rong S; Wang S; Shushakova N; Mengel M; Dettling A; Bang C; Scherf K; Koelling M; Melk A; Haller H; Thum T; Lorenzen JM
Kidney Int; 2017 Sep; 92(3):646-656. PubMed ID: 28396121
[TBL] [Abstract][Full Text] [Related]
10. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells.
Xu Z; Zhao C; Wang Z; Tao J; Han Z; Zhang W; Tan R; Gu M
Gene; 2018 Feb; 644():113-121. PubMed ID: 29122645
[TBL] [Abstract][Full Text] [Related]
12. ATG5-mediated autophagy suppresses NF-κB signaling to limit epithelial inflammatory response to kidney injury.
Peng X; Wang Y; Li H; Fan J; Shen J; Yu X; Zhou Y; Mao H
Cell Death Dis; 2019 Mar; 10(4):253. PubMed ID: 30874544
[TBL] [Abstract][Full Text] [Related]
13. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.
Deng J; Xia Y; Zhou Q; Wang X; Xiong C; Shao X; Shao M; Zou H
Transpl Immunol; 2019 Jun; 54():20-28. PubMed ID: 30682409
[TBL] [Abstract][Full Text] [Related]
15. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
Soltaninejad E; Nicknam MH; Nafar M; Sharbafi MH; Keshavarz Shahbaz S; Barabadi M; Yekaninejad MS; Bahrami T; Ahmadpoor P; Amirzargar A
Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):615-23. PubMed ID: 26725559
[TBL] [Abstract][Full Text] [Related]
16. Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions.
Pérez L; Muñoz-Durango N; Riedel CA; Echeverría C; Kalergis AM; Cabello-Verrugio C; Simon F
Cytokine Growth Factor Rev; 2017 Feb; 33():41-54. PubMed ID: 27692608
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
[TBL] [Abstract][Full Text] [Related]
18. Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach.
Li L; Greene I; Readhead B; Menon MC; Kidd BA; Uzilov AV; Wei C; Philippe N; Schroppel B; He JC; Chen R; Dudley JT; Murphy B
Sci Rep; 2017 Jan; 7():39487. PubMed ID: 28051114
[TBL] [Abstract][Full Text] [Related]
19. ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts.
Betjes MGH; Sablik KA; Litjens NHR; Otten HG; de Weerd AE
Hum Immunol; 2021 Feb; 82(2):89-96. PubMed ID: 33358038
[TBL] [Abstract][Full Text] [Related]
20. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model.
Guan Q; Li S; Gao S; Chen H; Nguan CY; Du C
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F199-207. PubMed ID: 23552866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
